| Features: |
| MNPs often used in combination with Magnetic field for thermal effects, or cell disruption. |
| 654- | EGCG, | MNPs, | MF, | Characterization of mesenchymal stem cells with augmented internalization of magnetic nanoparticles: The implication of therapeutic potential |
| - | in-vitro, | Var, | NA |
| 657- | EGCG, | MNPs, | MF, | Interaction of poly-l-lysine coating and heparan sulfate proteoglycan on magnetic nanoparticle uptake by tumor cells |
| - | in-vitro, | GBM, | U87MG |
| 658- | EGCG, | MNPs, | MF, | Laminin Receptor-Mediated Nanoparticle Uptake by Tumor Cells: Interplay of Epigallocatechin Gallate and Magnetic Force at Nano-Bio Interface |
| - | in-vitro, | GBM, | LN229 |
| 659- | EGCG, | MNPs, | MF, | Augmented cellular uptake of nanoparticles using tea catechins: effect of surface modification on nanoparticle-cell interaction |
| - | in-vivo, | Nor, | NA |
| 2250- | MF, | MNPs, | Confronting stem cells with surface-modified magnetic nanoparticles and low-frequency pulsed electromagnetic field |
| - | Review, | Var, | NA |
| 9300- | MFrot, | MNPs, | AgNPs, | Antibacterial Effects of Magnetically-Controlled Ag/Fe3O4 Nanoparticles |
| - | in-vitro, | Nor, | NA |
| 539- | MNPs, | Pulsed Magnetic Field Improves the Transport of Iron Oxide Nanoparticles through Cell Barriers |
| - | in-vitro, | Var, | NA |
| 582- | MNPs, | immuno, | VitC, | Magnetic field boosted ferroptosis-like cell death and responsive MRI using hybrid vesicles for cancer immunotherapy |
| - | in-vitro, | Pca, | TRAMP-C1 | - | in-vivo, | NA, | NA |
| 656- | MNPs, | MF, | Effects of combined delivery of extremely low frequency electromagnetic field and magnetic Fe3O4 nanoparticles on hepatic cell lines |
| - | in-vitro, | HCC, | HepG2 | - | in-vitro, | Nor, | HL7702 |
| 1762- | MNPs, | Fe, | Triggering the apoptosis of targeted human renal cancer cells by the vibration of anisotropic magnetic particles attached to the cell membrane |
| - | in-vitro, | RCC, | NA |
| 2257- | MNPs, | HPT, | HSP70 Inhibition Synergistically Enhances the Effects of Magnetic Fluid Hyperthermia in Ovarian Cancer |
| - | in-vitro, | Ovarian, | NA |
| 3458- | MNPs, | Magnetic Control of Protein Expression via Magneto-mechanical Actuation of ND-PEGylated Iron Oxide Nanocubes for Cell Therapy |
| - | in-vitro, | GBM, | NA |
| 5240- | MNPs, | Effect of low frequency magnetic fields on the growth of MNP-treated HT29 colon cancer cells |
| - | in-vitro, | Colon, | HT29 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:236 Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid